Hyderabad Telangana, India

Sarma K S Pakala


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sarma K S Pakala

Introduction

Sarma K S Pakala is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic compounds. With a total of four patents to his name, Pakala's work is recognized for its potential impact on diabetes treatment.

Latest Patents

One of Sarma K S Pakala's latest patents focuses on heterocyclic compounds, detailing a process for their preparation and pharmaceutical compositions containing them. This invention is particularly relevant for the treatment of diabetes and related diseases. It encompasses novel antidiabetic compounds, their tautomeric forms, derivatives, stereoisomers, polymorphs, and pharmaceutically acceptable salts and solvates. The invention specifically highlights novel azolidinedione derivatives of a general formula, along with their pharmaceutical compositions.

Career Highlights

Throughout his career, Sarma K S Pakala has worked with prominent organizations, including Dr. Reddy's Laboratories. His experience in the pharmaceutical industry has allowed him to contribute to innovative solutions in drug development.

Collaborations

Sarma K S Pakala has collaborated with notable colleagues such as Vidya Bhushan Lohray and Braj Bhushan Lohray. These collaborations have further enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Sarma K S Pakala's contributions to the field of pharmaceuticals, particularly in the development of antidiabetic compounds, showcase his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in diabetes treatment and related areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…